“Objective To identify key determinants of patient satisf


“Objective. To identify key determinants of patient satisfaction.\n\nDesign. Data used were obtained through a self-administered, post-visit questionnaire by random sampling during the period of January 2009 to September 2009.\n\nSetting. Thirty-nine hospitals in Germany.\n\nParticipants. A total of 8428 patients.\n\nMain Outcome Measure. Global patient satisfaction was measured by a single item question. Attributes of medical aspects of care were measured using 12 items, performance of service using 3 items and different dimensions of patient expectations

using 12 items. Medical aspects of care and performance of service items were entered into logistic regression analysis to identify determinants of patient satisfaction.\n\nResults. The results of the analysis

showed that there are 10 determinants of global GSK1210151A order patient satisfaction. The outcome of treatment was overall, the most salient predictor followed by nursing kindness as the second most important component. Items reflecting information receiving about the undergoing treatment do not have a major influence on patient satisfaction.\n\nConclusion. The analysis identified key determinants that should Selleck BVD-523 be altered first in order to improve global patient satisfaction. The results also indicate that some aspects of the hospital stay are not seen as relevant by patients and therefore are unrelated to satisfaction ratings. The findings suggest that variables measuring patients’ perceptions of care are more important determinants of global patient satisfaction in comparison to demographics and visit characteristics. Results of the present study have implications for health providers

aiming at improving the service quality and quality of care.”
“Systemic lupus erythematosus (SLE) is a prototypical autoimmune disease with strong genetic and environmental components. Previous studies have shown increased levels of several chemokines in active SLE. C-C chemokine receptor type 5 (CCR5) is involved in the recruitment of inflammatory cells into tissues, and mechanisms modulating CCR5 expression and function may interfere in SLE development, influencing the clinical course of the PP2 disease. The aim of this study was to evaluate the possible association between the CCR532 base-pair deletion polymorphism and SLE disease in a group of Portuguese patients. A total of 219 patients with SLE and 205 healthy individuals were studied. The frequency of CCR5/32 heterozygotes was lower in patients with SLE than in controls (8% vs. 15% OR=0.5162; P=0.0319), suggesting a protective association between CCR532 allele and SLE. These results highlight the protective role of Th1 cells that express CCR5 in SLE pathogenesis.”
“The electrical impedance of samples of mouse brain cortex has been measured between 4.7 kHz and 2.0 MHz.

Comments are closed.